\u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002
\nPublished papers are linked to PubMed<\/p>\n
<\/p>\n
Long-term transition of antibody titers in healthcare workers following the first to fourth doses of mRNA COVID-19 vaccine: comparison of two automated SARS-CoV-2 immunoassays.<\/p>\n J Infect Chemother. 29(5): 534-538, 2023 May<\/p>\n Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE.<\/p>\n Blood. 2023 Nov 23;142(21):1789-1805.<\/p>\n Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: a Japanese multicenter observational study.<\/p>\n Am J Hematol. 98(1): 102-111, 2023 Jan<\/p>\n Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.<\/p>\n Cancer Sci. 2023 Feb;114(2):596-605.<\/p>\n Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.<\/p>\n Sci Rep. 2023 Feb 14;13(1):2641.<\/p>\n Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: a phase 3, placebo-controlled, double-blind, parallel-group study.<\/p>\n Br J Haematol. 200(6): 802-811, 2023 Mar<\/p>\n What is the best preoperative quantitative indicator to differentiate primary central nervous system lymphoma from glioblastoma?<\/p>\n World Neurosurg. 172: e517-e523, 2023 Apr<\/p>\n CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.<\/p>\n Blood Adv. 7(12): 2699-2708, 2023 Jun<\/p>\n Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors.<\/p>\n Neuropathology. 43(3): 209-220, 2023 Jun<\/p>\n Clinical characteristics of Japanese patients with myelodysplastic.myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.<\/p>\n Int J Hematol. 118(1): 47-53, 2023 Jul<\/p>\n Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model.<\/p>\n Blood Cancer J. 13(1): 110, 2023 Jul<\/p>\n Long-term follow-up after R-High CHOP\/CHASER\/LEED with Auto-PBSCT in untreated mantle cell lymphoma \u2013 Final analysis of JCOG0406.<\/p>\n Cancer Sci. 114(8): 3461-3465, 2023 Aug<\/p>\n Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen : A supplementary analysis of JCOG1105.<\/p>\n Hematol Oncol. 41(3): 590-593, 2023 Aug<\/p>\n Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis.<\/p>\n Mod Rheumatol. 33(6): 1145-1153, 2023 Nov<\/p>\n A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan.<\/p>\n Hematology. 28(1): 2227817, 2023 Dec<\/p>\n \u514d\u75ab\u95a2\u9023\u6709\u5bb3\u4e8b\u8c61\uff08irAEs\uff09\u65e9\u671f\u767a\u898b\u306b\u5411\u3051\u305f\u526f\u4f5c\u7528\u81ea\u5df1\u7533\u544a\u578b\u554f\u8a3a\u30b7\u30b9\u30c6\u30e0\uff08ISRIS\uff09\u306e\u904b\u7528\u3068\u305d\u306e\u6709\u7528\u6027<\/p>\n \u764c\u3068\u5316\u5b66\u7642\u6cd5 50(1): 59-64, 2023 Jan<\/p>\n \u82f1\u6587\u539f\u8457\u8ad6\u6587\u3000Original papers \u767a\u520a\u6e08\u306e\u3082\u306e\u306fabstract\u307e\u305f\u306f\u672c\u6587\u306b\u30ea\u30f3\u30af\u3057\u3066\u3042\u308a\u307e\u3059\u3002 Published papers are linked to PubMed<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-3465","post","type-post","status-publish","format-standard","hentry","category-8"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t
\nTaniguchi, Y., Suemori, K., Tanaka, K., Okamoto, A., Murakami, A., Miyamoto, H., Takasuka, Y., Yamashita, M., Takenaka, K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nKonishi T, Ochi T, Maruta M, Tanimoto K, Miyazaki Y, Iwamoto C, Saitou T, Imamura T, Yasukawa M, Takenaka K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nMori, Y., Uchida, N., Harada, T., Katayama, Y., Wake, A., Iwasaki, H., Eto, T., Morishige, S., Fujisaki, T., Ito, Y., Kamimura, T., Takahashi, T., Imamura, Y., Tanimoto, K., Ishitsuka, K., Sugita, J., Kawano, N., Tanimoto, K., Yoshimoto, G., Choi, I., Hidaka, T., Ogawa, R., Takamatsu, Y., Miyamoto, T., Akashi, K., Nagafuji, K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nOgawa H, Konishi T, Najima Y, Kito S, Hashimoto S, Kato C, Sakai S, Kanbara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakasima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Shingai N, Toya T, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN.<\/a><\/a><\/p>\n
\n
\n <\/p>\n
\nKonishi T, Sadato D, Toya T, Hirama C, Kishida Y, Nagata A, Yamada Y, Shingai N, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Okuyama Y, Harada H, Ohashi K, Harada Y, Doki N.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nKuwana, M., Ito, T., Kowata, S., Hatta, Y., Fujimaki, K., Naito, K., Kurahashi, S., Kagoo, T., Tanimoto, K., Saotome, S., Tomiyama, Y.: R788-1301 Investigators.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nInoue, A., Matsumoto, S., Ohnishi, T., Miyazaki, Y., Kinnami, S., Kanno, K., Honda, T., Kurata, M., Taniwaki, M., Kusakabe, K., Suehiro, S., Yamashita, D., Shigekawa, S., Watanabe, H., Kitazawa, R., Kunieda, T.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nAkahoshi, Y., Nakasone, H., Takenaka, K., Yamasaki, S., Nakamura, M., Doki, N., Tanaka, M., Ozawa, Y., Uchida, N., Ara, T., Nakamae, H., Ota, S., Onizuka, M., Yano, S., Tanaka, J., Fukuda, T., Kanda, Y., Atsuta, Y., Kako, S., Yanada, M., Arai, Y.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nInoue, A., Watanabe, H., Kondo, T., Katayama, E., Miyazaki, Y., Suehiro, S., Yamashita, D., Taniwaki, M., Kurata, M., Shigekawa, S., Kitazawa, R., Kunieda, T.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nEdahiro, Y., Ochiai, T., Hashimoto, Y., Morishita, S., Shirane, S., Inano, T., Furuya, C., Koike, M., Noguchi, M., Usuki, K., Shiratsuchi, M., Nakajima, K., Ohtsuka, E., Tanaka, H., Kawata, E., Nakamae, M., Ueda, Y., Aota, Y., Sugita, Y., Ohara, S., Yamasaki, S., Asagoe, K., Yoshida, S., Yamanouchi, J., Suzuki, S., Kondo, T., Kanisawa, Y., Toyama, K., Omura, H., Mizuchi, D., Sakamaki, S., Ando, M., Komatsu, N.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nShide, K., Takenaka, K., Kitanaka, A., Numata, A., Kameda, T., Yamauchi, T., Inagaki, A., Mizuno, S., Takami, A., Ito, S., Hagihara, M., Usuki, K., Maekawa, T., Sunami, K., Ueda, Y., Tsutsui, M., Ando, M., Komatsu, N., Ozawa, K., Kurokawa, M., Arai, S., Mitani, K., Akashi, K., Shimoda, K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nOgura, M., Yamamoto, K., Morishima, Y., Wakabayashi, M., Tobinai, K., Ando, K., Uike, N., Kurosawa, M., Gomyo, H., Taniwaki, M., Nosaka, K., Tsukamoto, N., Shimoyama, T., Fukuhara, N., Yakushijin, Y., Ohnisihi, K., Miyazaki, K., Kameoka, Y., Takayama, N., Hanamura, I., Kobayashi, H., Usui, K., Kobayashi, N., Ohyashiki, K., Utsumi, T., Kumagai, K., Maruyama, D., Ohmachi, K., Matsuno, Y., Nakamura, S., Hotta, T., Tsukasaki, K., Nagai, H.<\/a><\/a><\/p>\n
\n
\n <\/p>\n
\nSuzuki, T., Maruyama, D., Machida, R., Kataoka, T., Fukushima, N., Takayama, N., Ohba, R., Omachi, K., Imaizumi, Y., Tokunaga, M., Katsuya, H., Yoshida, I., Sunami, K., Kurosawa, M., Kubota, N., Morimoto, H., Kobayashi, M., Yamamoto, K., Kameoka, Y., Kagami, Y., Tabayashi, T., Maruta, M., Kobayashi, T., Iida, S., Nagai, H.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nSugihara, T., Uchida, HA., Yoshifuji, H., Maejima, Y., Naniwa, T., Katsumata, Y., Okazaki, T., Ishizaki, J., Murakawa, Y., Ogawa, N., Dobashi, H., Horita, T., Tanaka, Y., Furuta, S., Takeuchi, T., Komagata, Y., Nakaoka, Y., Harigai, M.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\nEdahiro, Y., Kirito, K., Gotoh, A., Takenaka, K., Sugimoto, Y., Komatsu, N., Shimoda, K.<\/a><\/a><\/p>\n
\n
\n<\/p>\n
\n\u77e2\u91ce\u5b89\u6a39\u5b50, \u4e95\u9580\u9759\u9999, \u6e05\u5ddd\u8061\u7f8e, \u68ee\u5948\u6708, \u9577\u8c37\u90e8\u664b\u58eb, \u7af9\u5185\u4e00\u4eba, \u98db\u9df9\u7bc4\u660e, \u7530\u4e2d\u5b88, \u85ac\u5e2b\u795e\u82b3\u6d0b<\/a><\/a><\/p>\n
\n
\n<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"